ScoreWhy is Senores Pharmaceuticals Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.05 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 85.60% and Operating profit at 130.72%
3
With a growth in Net Profit of 11.49%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 3 consecutive quarters
- PAT(Latest six months) At Rs 64.04 cr has Grown at 113.32%
- NET SALES(Q) Highest at Rs 174.56 cr
- OPERATING PROFIT TO INTEREST(Q) Highest at 10.13 times
4
With ROE of 10.7, it has a Expensive valuation with a 4.5 Price to Book Value
- Over the past year, while the stock has generated a return of 57.47%, its profits have risen by 86%
5
Majority shareholders : Promoters
6
Market Beating Performance
- The stock has generated a return of 57.47% in the last 1 year, much higher than market (BSE500) returns of 9.20%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Senores Pharma. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Senores Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Senores Pharma.
57.07%
1.26
45.64%
Sensex
8.01%
0.70
11.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
85.60%
EBIT Growth (5y)
130.72%
EBIT to Interest (avg)
4.98
Debt to EBITDA (avg)
4.13
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.40
Tax Ratio
22.32%
Dividend Payout Ratio
0
Pledged Shares
1.90%
Institutional Holding
12.66%
ROCE (avg)
8.59%
ROE (avg)
10.70%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
32
Price to Book Value
4.49
EV to EBIT
28.41
EV to EBITDA
23.49
EV to Capital Employed
4.33
EV to Sales
6.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.35%
ROE (Latest)
10.70%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
PAT(Latest six months)
At Rs 64.04 cr has Grown at 113.32%
NET SALES(Q)
Highest at Rs 174.56 cr
OPERATING PROFIT TO INTEREST(Q)
Highest at 10.13 times
PBDIT(Q)
Highest at Rs 54.01 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 30.94%
PBT LESS OI(Q)
Highest at Rs 40.82 cr.
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Senores Pharma.
Profit After Tax (PAT) - Latest six months
At Rs 64.04 cr has Grown at 113.32%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 40.82 cr has Grown at 97.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 20.65 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 174.56 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 10.13 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales - Quarterly
At Rs 174.56 cr has Grown at 35.1% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 129.25 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 54.01 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 30.94%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 40.82 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
